BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 18647205)

  • 61. Regulation of p27
    Russo GL; Stampone E; Cervellera C; Borriello A
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32933137
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Increased expression of germinal center-associated nuclear protein (GANP) is associated with malignant transformation of melanocytes.
    Kageshita T; Kuwahara K; Oka M; Ma D; Ono T; Sakaguchi N
    J Dermatol Sci; 2006 Apr; 42(1):55-63. PubMed ID: 16431081
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma.
    Fang D; Hallman J; Sangha N; Kute TE; Hammarback JA; White WL; Setaluri V
    Am J Pathol; 2001 Jun; 158(6):2107-15. PubMed ID: 11395388
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Signal-induced ubiquitination of p57(Kip2) is independent of the C-terminal consensus Cdk phosphorylation site.
    Leibovitch MP; Kannengiesser C; Leibovitch SA
    FEBS Lett; 2003 May; 543(1-3):125-8. PubMed ID: 12753918
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The developmental expression of the CDK inhibitor p57(kip2) (Cdkn1c) in the early mouse placenta.
    Saunders AC; McGonnigal B; Uzun A; Padbury J
    Mol Reprod Dev; 2016 May; 83(5):405-12. PubMed ID: 26988311
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A pro-apoptotic effect of the CDK inhibitor p57(Kip2) on staurosporine-induced apoptosis in HeLa cells.
    Samuelsson MK; Pazirandeh A; Okret S
    Biochem Biophys Res Commun; 2002 Aug; 296(3):702-9. PubMed ID: 12176039
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Functional Versatility of the CDK Inhibitor p57
    Creff J; Besson A
    Front Cell Dev Biol; 2020; 8():584590. PubMed ID: 33117811
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness.
    Carreira S; Goodall J; Denat L; Rodriguez M; Nuciforo P; Hoek KS; Testori A; Larue L; Goding CR
    Genes Dev; 2006 Dec; 20(24):3426-39. PubMed ID: 17182868
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Expression and significance of P57(kip2) and Maspin in pathological scar].
    Cai YM; Zhu SZ; Zheng ZF; Yang WQ; Wu WY
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 Nov; 27(6):431-6. PubMed ID: 22292406
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases.
    Stampone E; Caldarelli I; Zullo A; Bencivenga D; Mancini FP; Della Ragione F; Borriello A
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29614816
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nuclear to cytoplasmic compartment shift of the p33ING1b tumour suppressor protein is associated with malignancy in melanocytic lesions.
    Nouman GS; Anderson JJ; Mathers ME; Leonard N; Crosier S; Lunec J; Angus B
    Histopathology; 2002 Apr; 40(4):360-6. PubMed ID: 11943021
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Expression of cyclins A and E in melanocytic skin lesions and its correlation with some clinicopathologic features.
    Alekseenko A; Wojas-Pelc A; Lis GJ; Wiśniowski Z; Czerwińska M; Niewiara Ł; Litwin JA
    Folia Histochem Cytobiol; 2012 Jul; 50(2):263-9. PubMed ID: 22763964
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of tubulin β-3 as a novel senescence-associated gene in melanocytic malignant transformation.
    Orfanidis K; Wäster P; Lundmark K; Rosdahl I; Öllinger K
    Pigment Cell Melanoma Res; 2017 Mar; 30(2):243-254. PubMed ID: 28024114
    [TBL] [Abstract][Full Text] [Related]  

  • 74. C-kit expression in canine mucosal melanomas.
    Newman SJ; Jankovsky JM; Rohrbach BW; LeBlanc AK
    Vet Pathol; 2012 Sep; 49(5):760-5. PubMed ID: 21825314
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Expression of the components of the Cip/Kip family in malignant lymphoma of the thyroid.
    Ito Y; Yoshida H; Matsuzuka F; Matsuura N; Nakamura Y; Nakamine H; Kakudo K; Kuma K; Miyauchi A
    Pathobiology; 2004; 71(3):164-70. PubMed ID: 15051930
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification of multiple cell cycle regulatory functions of p57Kip2 in human T lymphocytes.
    Li G; Domenico J; Lucas JJ; Gelfand EW
    J Immunol; 2004 Aug; 173(4):2383-91. PubMed ID: 15294951
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Protein patterns of benign and malignant human melanocytes show consistent changes in gene expression.
    Eberle J; Garbe C; Kroumpouzos G; Orfanos CE
    Recent Results Cancer Res; 1995; 139():123-35. PubMed ID: 7597285
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer.
    Kim YK; Yu J; Han TS; Park SY; Namkoong B; Kim DH; Hur K; Yoo MW; Lee HJ; Yang HK; Kim VN
    Nucleic Acids Res; 2009 Apr; 37(5):1672-81. PubMed ID: 19153141
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Melanoma-associated expression of transforming growth factor-beta isoforms.
    Van Belle P; Rodeck U; Nuamah I; Halpern AC; Elder DE
    Am J Pathol; 1996 Jun; 148(6):1887-94. PubMed ID: 8669474
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The hallmarks of CDKN1C (p57, KIP2) in cancer.
    Kavanagh E; Joseph B
    Biochim Biophys Acta; 2011 Aug; 1816(1):50-6. PubMed ID: 21447370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.